Logo Scientific Seminars

The 2024 Digital Learning Journey on Diabetes

The global prevalence of obesity, insulin resistance and diabetes continues to rise in a pathophysiological continuum. This phenomenon is mainly driven by the adoption of unhealthy lifestyles leading to increasing rates of obesity, which is recognized as the main modifiable risk factor for type 2 diabetes. Nonetheless, genetic predisposition is another key and non-modifiable risk factor for all insulin resistance, obesity and type 2 diabetes, which should be acknowledged when approaching this global health issue both clinically and for research purposes.  

The effects of insulin resistance and obesity go far beyond the impairment of glucose metabolism. As a matter of atherosclerotic cardiovascular disease remains the leading cause of morbidity and mortality for individuals with diabetes, representing a major burden for the whole society. Multiple mechanisms are involved in the pathogenesis of atherosclerosis among people with insulin resistance and diabetes and a multifactorial approach is needed.  Of note, vascular complications of diabetes potentially affect the whole organism, with several and multiorgan sequelae. Among these, diabetic foot is one of the most common complications in people with diabetes and can lead to serious infections and even amputations if not properly managed.

This digital learning journey aims at covering the actual gaps in knowledge in terms of epidemiology, risk factors and therapeutic strategies to prevent and tackle insulin resistance, obesity and type 2 diabetes and their vascular complications, with also a special focus on the consequences of obesity among women.

English

The Virtual Animated Conversation on PCOS and its link with insulin resistance will have Spanish voiceover

  • Update the actual knowledge about the multifactorial approach needed to manage cardiovascular risk in diabetes
  • Increasing confidence in implementing management strategies to decrease DFU burden
  • Acquire the basic knowledge about the relationship between insulin resistance and PCOS and potential therapeutic strategies
  • Increasing awareness of the long-term health risks and what needs to be done to reduce those risks among women with gestational diabetes mellitus (GDM) and their children

 

Diabetologist, endocrinologist, gynecologists, internal medicine and general practitioners, cardiologists, nutritionists and diabetes educators

This learning journey is a structured e-learning educational program comprising:

  • Virtual Animated Conversation: From insulin-resistance, to PCOS, to gestational diabetes: the journey of obese women

LAUNCH DATE:

  • Episode 1: 30 May 2024
  • Episode 2: 28 November 2024

 

  • Vodcast: Atherosclerotic disease: the unresolved issue of diabetes

LAUNCH DATE:

  • Episode 1: 30 April 2024
  • Episode 2: 16 September 2024

 

Endorsed by

  

Share on social

Sara Bassetti | Progamme Manager | sara.bassetti@scientificseminars.com

This educational program is made possible thanks to an independent educational grant received from Merck Healthcare KGaA, Darmstadt, Germany.

Scientific Seminars Foundation
My Agile Privacy
This website uses technical and profiling cookies. Clicking on "Accept" authorises all profiling cookies. Clicking on "Refuse" or the X will refuse all profiling cookies. By clicking on "Customise" you can select which profiling cookies to activate.
Warning: some page functionalities could not work due to your privacy choices